As of Jun 23, 2026, DVA's PEG ratio of 3.33 reflects its valuation relative to its growth rate. This result reflects a P/E ratio of 19.3 measured against EPS growth of 5.8%.
Davita's ten years historical PEG ratio averages out to 0.71. Compared to historical data, DVA's 3.33 PEG ratio represents an increase of 369%. DVA hit its maximum PEG ratio of 3.19 during the Sep 2025 quarter over the last ten years. The Mar 2020 quarter marked the lowest reading at 0.02, indicating the most attractive growth-adjusted valuation.
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| 2025 | N/A | 11.29 | -8.7% |
| 2024 | 0.3 | 13.57 | 44.6% |
| 2023 | 0.52 | 13.75 | 26.4% |
| 2022 | N/A | 12.38 | -35.2% |
| 2021 | 0.28 | 12.23 | 44% |
| 2020 | 0.82 | 18.17 | 22.1% |
| 2019 | 0.03 | 14.18 | 468.8% |
| 2018 | N/A | 55.33 | -73.6% |
| 2017 | N/A | 20.53 | -19.3% |
| 2016 | 0.06 | 14.72 | 243.3% |
| 2015 | N/A | 54.89 | -62.8% |
| 2014 | 1.72 | 22.21 | 12.9% |
| 2013 | 2.56 | 20.98 | 8.2% |
| 2012 | 1.92 | 19.81 | 10.3% |
| 2011 | 0.57 | 14.98 | 26.5% |
| Year | PEG ratio | PE ratio | Growth YoY |
|---|---|---|---|
| Mar 2026 | 2.42 | 14.06 | 5.8% |
| Dec 2025 | N/A | 11.29 | -8.7% |
| Sep 2025 | 3.19 | 13.39 | 4.2% |
| Jun 2025 | 1.8 | 13.71 | 7.6% |
| Mar 2025 | 1.06 | 14.81 | 14% |
| Dec 2024 | 0.3 | 13.57 | 44.6% |
| Sep 2024 | 0.41 | 17.22 | 41.5% |
| Jun 2024 | 0.17 | 14.34 | 86.1% |
| Mar 2024 | 0.25 | 15.24 | 61.5% |
| Dec 2023 | 0.52 | 13.75 | 26.4% |
| Sep 2023 | N/A | 14.05 | -5.3% |
| Jun 2023 | N/A | 19.36 | -38.4% |
| Mar 2023 | N/A | 14.46 | -36.3% |
| Dec 2022 | N/A | 12.38 | -35.2% |
| Sep 2022 | N/A | 11.64 | -20.9% |
When comparing to historical data, DVA's PEG ratio is above the 3, 5 and 10-year averages.
Davita's PEG of 3.33 is higher than the Healthcare sector, the industry and its peers average. In comparison with the Healthcare sector average of 0.56, Davita's PEG is 495% higher.
Among its peer stocks LH and THC, DVA's PEG ratio runs higher. At 3.33, Davita's PEG ratio sits higher than the peer group average of 0.33.
| Stock name | PEG ratio | Market cap |
|---|---|---|
| MD Mednax Inc | 0.04 | $1.96B |
| UHS Universal Health Services Inc | 0.18 | $8.83B |
| THC Tenet Healthcare Corp | 0.36 | $15.58B |
| LH Laboratory Corp Of America Holdings | 0.75 | $21.2B |
| DVA Davita Inc | 3.33 | $13.54B |
Based on Jun 23, 2026 data, DVA shows a PEG ratio of 3.33.
Across the past 3 years, DVA's PEG ratio has centered around 1.12.
Across the past 5 years, DVA's PEG ratio has centered around 0.93.
DVA is now at its ten years PEG ratio peak of 3.33.
At present, DVA's PEG ratio runs 369% higher than its 10-year historical average.
A 3.33 PEG ratio for DVA suggests the stock trades at a premium relative to its growth trajectory.
The PEG ratio derives from taking PE and dividing by the rate at which earnings are growing (YoY TTM). As of Jun 23, 2026, Davita carries a PE ratio of 19.3. Earnings grew at 5.8% over the TTM period ending Mar 2026. Applying the formula, this yields a PEG ratio of 3.33. PEG RATIO(3.33) = PE RATIO(19.3) / EPS GROWTH(5.8%)
All PEG ratio stats are based on quarterly TTM periods, unless otherwise specified.